Cargando…

Clinical Profile of Hyper-IgE Syndrome in India

Introduction: Hyper-IgE Syndrome (HIES) is a rare inborn error of immunity (IEI) characterized by a constellation of symptoms related to susceptibility to Staphylococcal skin and pulmonary infections, eczema, raised serum IgE (>2,000 IU/ml), craniofacial anomalies, and recurrent bone fractures. D...

Descripción completa

Detalles Bibliográficos
Autores principales: Saikia, Biman, Rawat, Amit, Minz, Ranjana W., Suri, Deepti, Pandiarajan, Vignesh, Jindal, Ankur, Sahu, Smrity, Karim, Adil, Desai, Mukesh, Taur, Prasad D., Pandrowala, Ambreen, Gowri, Vijaya, Madkaikar, Manisha, Dalvi, Aparna, Yadav, Reetika Mallik, Lashkari, Harsha Prasada, Raj, Revathi, Uppuluri, Ramya, Swaminathan, Venkateswaran V., Bhattad, Sagar, Cyril, Gladys, Kumar, Harish, Shukla, Anuj, Kalra, Manas, Govindaraj, Geeta, Singh, Surjit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952512/
https://www.ncbi.nlm.nih.gov/pubmed/33717144
http://dx.doi.org/10.3389/fimmu.2021.626593
_version_ 1783663742162042880
author Saikia, Biman
Rawat, Amit
Minz, Ranjana W.
Suri, Deepti
Pandiarajan, Vignesh
Jindal, Ankur
Sahu, Smrity
Karim, Adil
Desai, Mukesh
Taur, Prasad D.
Pandrowala, Ambreen
Gowri, Vijaya
Madkaikar, Manisha
Dalvi, Aparna
Yadav, Reetika Mallik
Lashkari, Harsha Prasada
Raj, Revathi
Uppuluri, Ramya
Swaminathan, Venkateswaran V.
Bhattad, Sagar
Cyril, Gladys
Kumar, Harish
Shukla, Anuj
Kalra, Manas
Govindaraj, Geeta
Singh, Surjit
author_facet Saikia, Biman
Rawat, Amit
Minz, Ranjana W.
Suri, Deepti
Pandiarajan, Vignesh
Jindal, Ankur
Sahu, Smrity
Karim, Adil
Desai, Mukesh
Taur, Prasad D.
Pandrowala, Ambreen
Gowri, Vijaya
Madkaikar, Manisha
Dalvi, Aparna
Yadav, Reetika Mallik
Lashkari, Harsha Prasada
Raj, Revathi
Uppuluri, Ramya
Swaminathan, Venkateswaran V.
Bhattad, Sagar
Cyril, Gladys
Kumar, Harish
Shukla, Anuj
Kalra, Manas
Govindaraj, Geeta
Singh, Surjit
author_sort Saikia, Biman
collection PubMed
description Introduction: Hyper-IgE Syndrome (HIES) is a rare inborn error of immunity (IEI) characterized by a constellation of symptoms related to susceptibility to Staphylococcal skin and pulmonary infections, eczema, raised serum IgE (>2,000 IU/ml), craniofacial anomalies, and recurrent bone fractures. Data on HIES from the Indian subcontinent is scarce and restricted to small case series and case reports. This is the first compilation of national data on HIES. Materials and Methods: A total 103 cases clinically diagnosed and treated as HIES were analyzed from nine centers. Cases with clinical and/or molecular diagnosis of DOCK8 deficiency were not included. Patients were divided into two groups: group I for whom a heterozygous rare variant of STAT3 was identified, and group II, with clinical features similar to those of AD STAT3 deficiency, but without any genetic diagnosis. Results: Genetic diagnosis was available in 27 patients (26.2%) and all harbored rare variants in the STAT3 gene. Majority of these STAT3 HIES patients presented with recurrent skin abscesses (77.7%) or pneumonia (62.9%) or both (59.2%). Other features included eczema (37%), candidiasis (55.5%), facial dysmorphism (55.5%), recurrent fractures (11.1%), and retained primary teeth (7.4%). Mycobacterial infections were seen in a significant 18.5%. Mortality was seen in three subjects (11.1%). A similar trend in the clinical presentation was observed when all the 103 patients were analyzed together. Twenty percent of patients without a rare variant in the STAT3 gene had an NIH score of ≥40, whereas, 51.9% of STAT3 HIES subjects had scores below the cut off of ≥40. TH17 cell numbers were low in 10/11 (90.9%) STAT3 HIES tested. Rare variants observed were 8 in exon 21; 8 in exon 13; 3 in exon 10; 2 in exon 15, and one each in exon 6, 16, 17, 19, 22, and splice site downstream of exon 12. Seven variants were novel and included F174S, N567D, L404Sfs(*)8, G419 =, M329K, T714I, R518X, and a splice site variant downstream of exon 12. Conclusions: The report includes seven novel STAT3 variants, including a rare linker domain nonsense variant and a CC domain variant. Mycobacterial diseases were more frequent, compared to western literature.
format Online
Article
Text
id pubmed-7952512
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-79525122021-03-13 Clinical Profile of Hyper-IgE Syndrome in India Saikia, Biman Rawat, Amit Minz, Ranjana W. Suri, Deepti Pandiarajan, Vignesh Jindal, Ankur Sahu, Smrity Karim, Adil Desai, Mukesh Taur, Prasad D. Pandrowala, Ambreen Gowri, Vijaya Madkaikar, Manisha Dalvi, Aparna Yadav, Reetika Mallik Lashkari, Harsha Prasada Raj, Revathi Uppuluri, Ramya Swaminathan, Venkateswaran V. Bhattad, Sagar Cyril, Gladys Kumar, Harish Shukla, Anuj Kalra, Manas Govindaraj, Geeta Singh, Surjit Front Immunol Immunology Introduction: Hyper-IgE Syndrome (HIES) is a rare inborn error of immunity (IEI) characterized by a constellation of symptoms related to susceptibility to Staphylococcal skin and pulmonary infections, eczema, raised serum IgE (>2,000 IU/ml), craniofacial anomalies, and recurrent bone fractures. Data on HIES from the Indian subcontinent is scarce and restricted to small case series and case reports. This is the first compilation of national data on HIES. Materials and Methods: A total 103 cases clinically diagnosed and treated as HIES were analyzed from nine centers. Cases with clinical and/or molecular diagnosis of DOCK8 deficiency were not included. Patients were divided into two groups: group I for whom a heterozygous rare variant of STAT3 was identified, and group II, with clinical features similar to those of AD STAT3 deficiency, but without any genetic diagnosis. Results: Genetic diagnosis was available in 27 patients (26.2%) and all harbored rare variants in the STAT3 gene. Majority of these STAT3 HIES patients presented with recurrent skin abscesses (77.7%) or pneumonia (62.9%) or both (59.2%). Other features included eczema (37%), candidiasis (55.5%), facial dysmorphism (55.5%), recurrent fractures (11.1%), and retained primary teeth (7.4%). Mycobacterial infections were seen in a significant 18.5%. Mortality was seen in three subjects (11.1%). A similar trend in the clinical presentation was observed when all the 103 patients were analyzed together. Twenty percent of patients without a rare variant in the STAT3 gene had an NIH score of ≥40, whereas, 51.9% of STAT3 HIES subjects had scores below the cut off of ≥40. TH17 cell numbers were low in 10/11 (90.9%) STAT3 HIES tested. Rare variants observed were 8 in exon 21; 8 in exon 13; 3 in exon 10; 2 in exon 15, and one each in exon 6, 16, 17, 19, 22, and splice site downstream of exon 12. Seven variants were novel and included F174S, N567D, L404Sfs(*)8, G419 =, M329K, T714I, R518X, and a splice site variant downstream of exon 12. Conclusions: The report includes seven novel STAT3 variants, including a rare linker domain nonsense variant and a CC domain variant. Mycobacterial diseases were more frequent, compared to western literature. Frontiers Media S.A. 2021-02-26 /pmc/articles/PMC7952512/ /pubmed/33717144 http://dx.doi.org/10.3389/fimmu.2021.626593 Text en Copyright © 2021 Saikia, Rawat, Minz, Suri, Pandiarajan, Jindal, Sahu, Karim, Desai, Taur, Pandrowala, Gowri, Madkaikar, Dalvi, Yadav, Lashkari, Raj, Uppuluri, Swaminathan, Bhattad, Cyril, Kumar, Shukla, Kalra, Govindaraj and Singh. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Saikia, Biman
Rawat, Amit
Minz, Ranjana W.
Suri, Deepti
Pandiarajan, Vignesh
Jindal, Ankur
Sahu, Smrity
Karim, Adil
Desai, Mukesh
Taur, Prasad D.
Pandrowala, Ambreen
Gowri, Vijaya
Madkaikar, Manisha
Dalvi, Aparna
Yadav, Reetika Mallik
Lashkari, Harsha Prasada
Raj, Revathi
Uppuluri, Ramya
Swaminathan, Venkateswaran V.
Bhattad, Sagar
Cyril, Gladys
Kumar, Harish
Shukla, Anuj
Kalra, Manas
Govindaraj, Geeta
Singh, Surjit
Clinical Profile of Hyper-IgE Syndrome in India
title Clinical Profile of Hyper-IgE Syndrome in India
title_full Clinical Profile of Hyper-IgE Syndrome in India
title_fullStr Clinical Profile of Hyper-IgE Syndrome in India
title_full_unstemmed Clinical Profile of Hyper-IgE Syndrome in India
title_short Clinical Profile of Hyper-IgE Syndrome in India
title_sort clinical profile of hyper-ige syndrome in india
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952512/
https://www.ncbi.nlm.nih.gov/pubmed/33717144
http://dx.doi.org/10.3389/fimmu.2021.626593
work_keys_str_mv AT saikiabiman clinicalprofileofhyperigesyndromeinindia
AT rawatamit clinicalprofileofhyperigesyndromeinindia
AT minzranjanaw clinicalprofileofhyperigesyndromeinindia
AT surideepti clinicalprofileofhyperigesyndromeinindia
AT pandiarajanvignesh clinicalprofileofhyperigesyndromeinindia
AT jindalankur clinicalprofileofhyperigesyndromeinindia
AT sahusmrity clinicalprofileofhyperigesyndromeinindia
AT karimadil clinicalprofileofhyperigesyndromeinindia
AT desaimukesh clinicalprofileofhyperigesyndromeinindia
AT taurprasadd clinicalprofileofhyperigesyndromeinindia
AT pandrowalaambreen clinicalprofileofhyperigesyndromeinindia
AT gowrivijaya clinicalprofileofhyperigesyndromeinindia
AT madkaikarmanisha clinicalprofileofhyperigesyndromeinindia
AT dalviaparna clinicalprofileofhyperigesyndromeinindia
AT yadavreetikamallik clinicalprofileofhyperigesyndromeinindia
AT lashkariharshaprasada clinicalprofileofhyperigesyndromeinindia
AT rajrevathi clinicalprofileofhyperigesyndromeinindia
AT uppuluriramya clinicalprofileofhyperigesyndromeinindia
AT swaminathanvenkateswaranv clinicalprofileofhyperigesyndromeinindia
AT bhattadsagar clinicalprofileofhyperigesyndromeinindia
AT cyrilgladys clinicalprofileofhyperigesyndromeinindia
AT kumarharish clinicalprofileofhyperigesyndromeinindia
AT shuklaanuj clinicalprofileofhyperigesyndromeinindia
AT kalramanas clinicalprofileofhyperigesyndromeinindia
AT govindarajgeeta clinicalprofileofhyperigesyndromeinindia
AT singhsurjit clinicalprofileofhyperigesyndromeinindia